[go: up one dir, main page]

MX2009006735A - Capsulas de gelatina que comprenden un acido. - Google Patents

Capsulas de gelatina que comprenden un acido.

Info

Publication number
MX2009006735A
MX2009006735A MX2009006735A MX2009006735A MX2009006735A MX 2009006735 A MX2009006735 A MX 2009006735A MX 2009006735 A MX2009006735 A MX 2009006735A MX 2009006735 A MX2009006735 A MX 2009006735A MX 2009006735 A MX2009006735 A MX 2009006735A
Authority
MX
Mexico
Prior art keywords
acid
gelatin capsules
pharmaceutically acceptable
pharmaceutical composition
acceptable acid
Prior art date
Application number
MX2009006735A
Other languages
English (en)
Inventor
Isabel Ottinger
Agnes Taillardat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37890457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006735(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009006735A publication Critical patent/MX2009006735A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica en la forma de una cápsula de gelatina, la cual comprende un ácido farmacéuticamente aceptable.
MX2009006735A 2006-12-20 2007-12-18 Capsulas de gelatina que comprenden un acido. MX2009006735A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126698 2006-12-20
PCT/EP2007/011138 WO2008074479A1 (en) 2006-12-20 2007-12-18 Gelatin capsules comprising an acid

Publications (1)

Publication Number Publication Date
MX2009006735A true MX2009006735A (es) 2009-06-30

Family

ID=37890457

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006735A MX2009006735A (es) 2006-12-20 2007-12-18 Capsulas de gelatina que comprenden un acido.

Country Status (15)

Country Link
US (1) US20100068265A1 (es)
EP (1) EP2120889A1 (es)
JP (1) JP2010513351A (es)
KR (1) KR20090094373A (es)
CN (1) CN101563072A (es)
AR (1) AR064419A1 (es)
AU (1) AU2007334856A1 (es)
BR (1) BRPI0720489A2 (es)
CA (1) CA2672400A1 (es)
CL (1) CL2007003698A1 (es)
MX (1) MX2009006735A (es)
PE (1) PE20081482A1 (es)
TW (1) TW200833375A (es)
UY (1) UY30810A1 (es)
WO (1) WO2008074479A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5829607B2 (ja) * 2010-06-30 2015-12-09 持田製薬株式会社 ω３脂肪酸の配合製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
DE4001622A1 (de) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
US5620704A (en) * 1994-11-07 1997-04-15 Warner-Lambert Company Process for stabilizing gelatin products
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1997033568A1 (en) * 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6228894B1 (en) * 1998-04-17 2001-05-08 Enhanced Derm Technologies, Inc. Softgel-compatible composition containing retinol
ATE387191T1 (de) * 2002-04-25 2008-03-15 Banner Pharmacaps Inc Kaubare weichkapsel
AU2003240536B2 (en) * 2002-06-05 2007-11-15 Ivax Pharmaceuticals, S.R.O. Reduction of gelatin cross-linking

Also Published As

Publication number Publication date
US20100068265A1 (en) 2010-03-18
TW200833375A (en) 2008-08-16
WO2008074479A1 (en) 2008-06-26
PE20081482A1 (es) 2008-12-23
UY30810A1 (es) 2008-07-31
KR20090094373A (ko) 2009-09-04
CL2007003698A1 (es) 2008-07-18
CA2672400A1 (en) 2008-06-26
BRPI0720489A2 (pt) 2014-02-04
CN101563072A (zh) 2009-10-21
JP2010513351A (ja) 2010-04-30
EP2120889A1 (en) 2009-11-25
AR064419A1 (es) 2009-04-01
AU2007334856A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
PL2046298T3 (pl) Farmaceutyczna postać dawkowania zawierająca farmaceutycznie dopuszczalną kompozycję solubilizującą
EA201290982A1 (ru) Фармацевтические композиции, препятствующие злоупотреблению
WO2009088414A3 (en) Oral pharmaceutical dosage forms
WO2011101866A3 (en) Gastric retention formulation containing baclofen
MX2009011165A (es) Formulaciones farmaceuticas que contienen derivados del acido lipoico.
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
MX2010007083A (es) Combinacion anti-retroviral.
FR2909867B3 (fr) Capsule remplie d'un medicament, en particulier d'un medicament inhalable.
MX2013001985A (es) Formulaciones a base de nalbufina y sus usos
WO2010127205A3 (en) Fixed dose drug combination formulations
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
ZA200701443B (en) Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations
DK1711169T3 (da) Coatede mikrodepottabletter med venlafaxinhydrochlorid
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
GB0703674D0 (en) A Process For The Preparation of an Orally Administered Unit Dose Tablet
PL1941263T3 (pl) Optyczna półilościowa 100% kontrola napełniania kapsułek farmaceutycznych na maszynach do napełniania kapsułek
MX2009006735A (es) Capsulas de gelatina que comprenden un acido.
PT1858494E (pt) Nova cápsula de gelatina mole
GB0624498D0 (en) Pharmaceutical compositon containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
WO2012111961A3 (ko) 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
WO2008062449A3 (en) A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol
EA201291118A1 (ru) Нутрицевтические и фармацевтические композиции, покрытые оболочкой из жевательной резинки
WO2005058275A3 (en) Ingestible capsules containing ethanol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal